PRISYM ID Achieves Zebra Technologies Validation
PRISYM 360 label management software has been tested by Zebra’s Global Enablement Center to support customers’ critical printing needs, reducing risk and deployment times
PRISYM ID announced it has successfully completed Zebra’s Enterprise Testing Program for its PRISYM 360 labeling solution. This designation indicates to customers and partners that PRISYM 360 was successfully tested, confirming its performance and functionality with Zebra ZT400, ZT600 and Xi4 series printers.
Provided as a cloud or on-premise solution, PRISYM 360 is designed specifically to address the unique complexities of medical device, clinical trial and pharmaceutical labeling and packaging artwork. By focusing on the data, PRISYM 360 provides the ability to control and optimize data to create a fully integrated approach to label management along the complete lifecycle, from design through to inspection.
“Working closely with Zebra engineering teams, we have tested the interoperability of PRISYM 360 with select products, including the ZT400, ZT600 and Xi4 printers that are extensively used by many of our customers,” said Chris Lentz, VP Cloud Platform, PRISYM ID. “This assures our Life Sciences customers that our application supports their critical printing needs and reduces both the risk and the deployment time.”
Zebra Technologies’ Enterprise Testing Program enables eligible channel partners to test the interoperability of their software and hardware solutions with select Zebra mobile computers, scanners, printers, RFID solutions and software products, to meet user application-specific needs.
About PRISYM ID
PRISYM ID provides regulated content and label management solutions designed specifically for life science companies and medical device manufacturers, improving patient safety and health outcomes whilst ensuring regulatory compliance. PRISYM ID’s unique products and technologies are used to assure compliance globally, for 10 million+ medical device, clinical trial and pharmaceutical products annually.
Andrew Baud, Distil, email@example.com, +44 (0) 7775 715775